Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
| ▸ | PPARG | P37231 | 11/20 | 0.42 |
| ▸ | PPARA | Q07869 | 11/20 | 0.42 |
| ▸ | CYP4F2 | P78329 | 3/20 | 0.39 |
| ▸ | CYP4A11 | Q02928 | 3/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | P4HTM | Q9NXG6 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6112960 | 0.80 | SMN1; SMN2 (0.48) | SMN1; SMN2PPARGPPARACYP4F2CYP4A11 | |
| SCHEMBL6112957 | 0.80 | SMN1; SMN2 (0.48) | SMN1; SMN2PPARGPPARACYP4F2CYP4A11 | |
| SCHEMBL6112971 | 0.76 | SMN1; SMN2 (0.52) | SMN1; SMN2PPARGPPARACYP4F2CYP4A11 | |
| SCHEMBL20665993 | 0.76 | DRD3 (0.44) | ALDH1A1P4HTM | |
| SCHEMBL20133266 | 0.75 | ACACB (0.36) | SMN1; SMN2 | |
| SCHEMBL20330345 | 0.73 | ABL1 (0.37) | SMN1; SMN2ALDH1A1P4HTM | |
| SCHEMBL18592271 | 0.72 | ABL1 (0.36) | ALDH1A1P4HTM | |
| SCHEMBL11550284 | 0.72 | SMN1; SMN2 (0.67) | SMN1; SMN2PPARGPPARA | |
| SCHEMBL27812384 | 0.72 | ACACB (0.44) | PPARGPPARAALDH1A1P4HTM | |
| SCHEMBL27410147 | 0.72 | P4HTM (0.53) | SMN1; SMN2ALDH1A1P4HTM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9725438-B2 | Substituted phenylazole derivative | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2017-08-08 | — | — | US | disclosed |
| US-9725438-B2 | Substituted phenylazole derivative | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2017-08-08 | — | — | US | disclosed |
| US-9725438-B2 | Substituted phenylazole derivative | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2017-08-08 | — | — | US | disclosed |
| EP-3009433-B1 | 2-PHENYL-1,3-OXAZOLE AND 5-PHENYL-1,2,4-OXADIAZOLE DERIVATIVES FOR THE TREATMENT OF DIABETES | DAIICHI SANKYO CO LTD (JP) | 2017-06-21 | — | — | EP | disclosed |
| EP-2805941-B1 | SUBSTITUTED PHENYLAZOLE DERIVATIVE | DAIICHI SANKYO CO LTD (JP) | 2016-08-17 | — | — | EP | disclosed |
| EP-3009433-A1 | 2-PHENYL-1,3-OXAZOLE AND 5-PHENYL-1,2,4-OXADIAZOLE DERIVATIVES FOR THE TREATMENT OF DIABETES | Daiichi Sankyo Company, Limited (JP) | 2016-04-20 | — | — | EP | disclosed |
| US-20160090375-A1 | SUBSTITUTED PHENYLAZOLE DERIVATIVE | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2016-03-31 | — | — | US | disclosed |
| US-20160090375-A1 | SUBSTITUTED PHENYLAZOLE DERIVATIVE | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2016-03-31 | — | — | US | disclosed |
| US-20160090375-A1 | SUBSTITUTED PHENYLAZOLE DERIVATIVE | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2016-03-31 | — | — | US | disclosed |
| US-20160081993-A1 | SUBSTITUTED PHENYLAZOLE DERIVATIVE | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2016-03-24 | — | — | US | disclosed |
| US-20160081993-A1 | SUBSTITUTED PHENYLAZOLE DERIVATIVE | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2016-03-24 | — | — | US | disclosed |
| US-20160081993-A1 | SUBSTITUTED PHENYLAZOLE DERIVATIVE | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2016-03-24 | — | — | US | disclosed |
| US-9233958-B2 | Substituted phenylazole derivatives | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2016-01-12 | — | — | US | disclosed |
| US-9233958-B2 | Substituted phenylazole derivatives | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2016-01-12 | — | — | US | disclosed |
| US-9233958-B2 | Substituted phenylazole derivatives | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2016-01-12 | — | — | US | disclosed |
| US-20140357675-A1 | Substituted Phenylazole Derivatives | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2014-12-04 | — | — | US | disclosed |
| US-20140357675-A1 | Substituted Phenylazole Derivatives | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2014-12-04 | — | — | US | disclosed |
| US-20140357675-A1 | Substituted Phenylazole Derivatives | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2014-12-04 | — | — | US | disclosed |
| EP-2805941-A1 | SUBSTITUTED PHENYLAZOLE DERIVATIVE | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2014-11-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160081993-A1 | SUBSTITUTED PHENYLAZOLE DERIVATIVE | IAPP, SLC5A1, GPR119 | SMN1; SMN2 1928/4885PPARG 68/4885PPARA 120/4885 |
| US-20160090375-A1 | SUBSTITUTED PHENYLAZOLE DERIVATIVE | IAPP, SLC5A1, GPR119 | SMN1; SMN2 1928/4885PPARG 68/4885PPARA 120/4885 |
| US-20140357675-A1 | Substituted Phenylazole Derivatives | IAPP, SLC5A1, GPR119 | SMN1; SMN2 1910/4885PPARG 65/4885PPARA 129/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.